The Art of the MedTech Real Estate Deal – Accelerating Innovation & Mitigating Risk Webinar

Matt Jackson – Executive Managing Director, JLL

Matt Jackson is an Executive Managing Director in JLL’s Business Consulting Group. He is based in Washington DC. Mr. Jackson is responsible for assisting companies with global strategy, location footprint configuration, location/site selection, portfolio and occupancy strategy, and global incentives negotiations. Matt has 22 years of experience assisting corporations with complex footprint configuration initiatives that achieve revenue, margin, integration and innovation objectives. He has conducted more than 400 related engagements for corporate clients and has recently negotiated investment agreements valued at more than US$6 billion. 

Having dedicated a career to global challenges, Matt brings a unique perspective to solving such issues. He has worked extensively in many of the world’s key investment markets.

Matt has been interviewed and written articles on global location footprint strategy, portfolio and occupancy related topics for Time International, Industry Week, LA Business Journal, USA today, Commercial Property News, Business Expansion Journal, CoreNet, Global Corporate Xpansion, Area Development, Supply Chain Management, Pharmaceutical Commerce and the Journal of Business Strategy. He is also a frequent presenter at industry conferences such as CoreNet, and IAMC. 

Joe Judge –  Executive Managing Director of MedTech & Life Sciences, JLL

Joe Judge is an Executive Managing Director of JLL’s MedTech & Life Sciences Practice.  Over the past 24 years Joe has developed relationships with and managed a wide variety of advisory and brokerage assignments ranging from global, national and regional headquarter relocations to consolidation studies for portfolio clients within the Medical Device and Life Science sectors throughout North America and across the globe. Joe is the active President of JLL’s Brokerage Leadership Board, which provides strategic insight to drive and enhance results at every level of JLL’s brokerage business. In 2020, Joe was presented with JLL’s highest honor, The Champion of Excellence, recognizing an employee that most exemplifies their values of teamwork, ethics and excellence. 

Anthony Fernando –  President & CEO, Asensus Surgical

As President and Chief Executive Officer, Mr. Fernando sets the company’s overall strategic vision and oversees its organic growth. Previously, he was the Chief Operating Officer and Chief Technology Officer at Asensus, where he led the company’s technology strategy and global business operations.

Prior to Asensus, Mr. Fernando was Vice President of Innovation and Technology within the International Group at Stryker Corporation, across Stryker’s medical device portfolio. Before joining Stryker, Mr. Fernando held positions at Becton Dickinson & Company as Director, R&D Devices & Global Health, Greater Asia; PerkinElmer Inc. as Director, R&D and CoE Leader in Asia; and Varian, Inc. as Director of Operations/General Manager of the Pharmaceutical Products business unit.

Mr. Fernando earned an MBA from the Kenan-Flagler Business School at the University of North Carolina, Chapel Hill, and MS and BS in Mechanical Engineering with concentrations in Robotics and Automation from the University of Nevada-Las Vegas.